当前位置:首页》》外文报告
招银国际-China Property Sector – Equity financing reopens to fuel another rally-221129 20221129 557KB
招银国际-Q-Tech (1478 HK) Corp Day Takeaways: Expect 4Q22E QoQ improvement; non-handset to accelerate in 2023-221129 20221129 1459KB
招银国际-Pinduoduo (PDD US) Strong revenue and earnings growth-221129 20221129 934KB
招银国际-Fixed Income Daily Market Update -221128 20221128 799KB
招银国际-Bosideng (3998 HK) An inline 1H9/23 result but the macro is at risk-221128 20221128 1907KB
招银国际-Meituan (3690 HK) Long-term development intact despite short-term headwinds-221128 20221128 1253KB
招商证券(香港)-CPIC (2601 HK) Agent force quality improved; Maintain BUY-221125 20221127 1653KB
招商证券(香港)-Macro Report:Growth in advanced economies slowed further in November -221124 20221125 720KB
招商证券(香港)-Anta Sports (2020 HK) Recent COVID restrictions negatively affect GMV -221124 20221125 1313KB
招银国际-EC Healthcare (2138 HK) Strong post-COVID business rebound-221125 20221125 1050KB
招银国际-Fixed Income Daily Market Update -221124 20221124 822KB
招商证券(香港)-Gaotu Group (GOTU US) Improving growth trajectory visibility-221123 20221124 1724KB
招商证券(香港)-CSPC PHARMA (1093 HK) 3Q22 net profit in-line, but oncology pressure remains -221123 20221124 1388KB
招银国际-Asian AT1s Part III – Picks on EM AT1s-221124 20221124 1215KB
招银国际-Xiaomi (1810 HK) Weak 3Q22 as anticipated; Expect sequential recovery ahead-221124 20221124 1417KB
招银国际-China Policy– China signaled further policy easing to boost growth-221124 20221124 870KB
招银国际-CSPC Pharmaceutical (1093 HK) Promising clinical progress of mRNA COVID-19 vaccine candidate-221124 20221124 1078KB
招银国际-Fixed Income Daily Market Update -221123 20221123 728KB
UOB-Markets Overview-221123 20221123 2821KB
招商证券(香港)-China Mengniu Dairy (2319 HK) Sales likely affected by rebound in COVID -221122 20221123 1380KB
 
<<<12345678910...>>>共467条 当前页:1 总页数:24 显示第1条到20条记录